Related Experiment Video

Updated: Mar 22, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.4K

Active Invasive Fungal Infection in a Patient With Severe Aplastic Anemia

Soner Solmaz1, Asli Korur, Mahmut Yeral

  • 1From the Başkent University Adana Adult Bone Marrow Transplantation Center, Adana, Turkey.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|April 12, 2016
PubMed

Insights

Severe aplastic anemia (SAA) is often fatal without treatment. This study examines treatment for invasive fungal infections in SAA patients, highlighting challenges with current antifungal therapies and hematopoietic stem cell transplantation.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Transplantation

Background:

  • Severe aplastic anemia (SAA) is a life-threatening condition requiring prompt treatment.
  • Invasive fungal infections (IFIs), especially Aspergillus species, are a significant cause of mortality in SAA patients.
  • Limited data exists on managing IFIs in SAA, particularly concerning hematopoietic stem cell transplantation (HSCT).

Purpose of the Study:

  • To discuss treatment strategies for severe aplastic anemia patients with invasive fungal infections.
  • To highlight the challenges in treating IFIs in immunocompromised SAA patients.
  • To review current antifungal therapies and their efficacy in SAA.

Main Methods:

  • Case study analysis of two SAA patients with IFIs.
  • Review of existing literature on IFI management in SAA.
  • Discussion of treatment scenarios including antifungal therapy and HSCT.

Main Results:

  • Current antifungal drugs like voriconazole and liposomal amphotericin B show limited efficacy (around 30% recovery) in neutropenic SAA patients with persistent fever.
  • There is a lack of published data on the outcomes of HSCT in SAA patients with active IFIs.
  • Treatment decisions for IFIs in SAA require careful consideration of patient-specific factors and available therapeutic options.

Conclusions:

  • Managing invasive fungal infections in severe aplastic anemia is complex, with current therapies offering suboptimal outcomes.
  • Hematopoietic stem cell transplantation in the context of active invasive fungal infection in SAA patients warrants further investigation.
  • Developing effective treatment protocols for IFIs in SAA is crucial to improve patient survival rates.

More Related Videos

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

6.0K
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.8K

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
20
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
690
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K